The current three hospital study is only for infants and children up to the age of 12. Assuming the percentage of correct diagnosis by the algorithms is the same or better than in Australia, is this on its own good enough for FDA approval? What about testing on adults? Surely this is at least as important for the total acceptance by the market?
Or am I missing something?
- Forums
- ASX - By Stock
- RAP
- RAP - The Main Game
RAP - The Main Game, page-1183
-
- There are more pages in this discussion • 422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable